The Genetics of Primary Ovarian Insufficiency
The Genetics of Primary Ovarian Insufficiency
批准号:
9389173
负责人:
CORRINE K WELT
金额:
$30.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-06 至 2019-08-31
关键词:
AddressAffectAgeAgingAlgorithmic SoftwareBiologyCarrier ProteinsCodeComorbidityComputer softwareDNA Sequence AlterationDNA Sequence AnalysisDatabasesDevelopmentDiseaseEarly identificationEtiologyEukaryotic Initiation FactorsFamilyFertilityFunctional disorderGene MutationGenealogyGenerationsGenesGeneticGenetic screening methodGrowthHealthHeritabilityInfertilityInheritance PatternsInheritedMedicalMeiosisMenopauseMessenger RNAMinorityMitochondrial InheritanceModelingMorbidity - disease rateMusMutationOocytesOvarianPathway interactionsPhenotypePolyribosomesPopulationPopulation DatabasePremature MenopausePremature Ovarian FailurePrevalenceProteinsRNA polymerase II largest subunitRecording of previous eventsRecruitment ActivityRegulationRepressor ProteinsResearchRiskSyndromeTestingTranslatingTranslationsUniversitiesUtahVariantWomanWorkbasecohortdisorder riskexomeexome sequencinggenetic pedigreegenome sequencingimprovedmortalitymouse modelnext generation sequencingnovelprediction algorithmprimary ovarian insufficiencyprotein transportreproductive senescencescreeningsegregationsoftware developmenttargeted treatmentwhole genome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summary
Primary ovarian insufficiency (POI) is part of the continuum of ovarian dysfunction ranging from infertility with a
high FSH level to early menopause before age 45 years, and affects 5-10% of women. Using next generation
sequencing in women with familial POI, we have identified novel, heterozygous, stop gained mutations in two
families. The first was in the eukaryotic translation initiation factor transport protein eIF4ENIF1, which causes
menopause 20 years earlier than the population average. The second was in POLR2C, the third largest
subunit of RNA polymerase II, which appears to cause earlier menopause in each generation. We will now
apply unique DNA sequence analysis software developed at the University of Utah to discover novel gene
mutations in sporadic POI and familial POI cases. In addition, we will examine the familial segregation of POI
and comorbid disease. Finally, we will use a mouse model of the eIF4ENIF1 stop gained mutation to identify
genes important for oocyte growth and meiosis. Specific Aim 1 will determine the breadth of genetic mutations
in large populations of women with POI that have undergone whole exome sequencing. We will use novel
software (VAAST, pVAAST and Phevor) developed at the University of Utah and controls recruited for health in
old age to prioritize variants in two POI cohorts with replication in a third (n~300). The software identifies rare,
damaging variants in genes that have a strong relationship to the POI phenotype. Specific Aim 2 will identify
familial cases of POI in the Utah Population Database, the most extensive genealogical database in the U.S.
The inheritance pattern, associated phenotypes and comorbid diseases will be analyzed in familial POI to
determine its effect on overall health and to determine families at risk for POI. Specific Aim 3 will determine
the mechanism of ovarian insufficiency in carriers of the eIF4ENIF1 stop gained mutation using a mouse
model. The differentially translated mRNA in polysomes in the presence of the stop gained mutation compared
to wild type will be determined. The differentially translated mRNAs in the eIF4ENIF1 stop gained mouse
model will highlight the genes important for oocyte development and meiosis, and will inform the search for
gene mutations in Specific Aim 1. The work will address two research gaps by illuminating our understanding
of the genetics of the reproductive aging transition. It will also address fertility as a marker of overall health by
identifying diseases associated with decreased ovarian reserve and POI. We will then be able to use family
history and associated disorders to identify women at risk for POI. New gene mutations and pathways will
inform software algorithms such as Phevor, which will use the new information to prioritize variants discovered
in next generation sequencing to determine the genetic cause of POI in additional women. Early identification
will bring the potential to preserve fertility and create targeted treatment options for these women.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.xfnr.2021.04.001
发表时间:
2021-07
期刊:
F&S reviews
影响因子:
--
作者:
[Verrilli, Lauren, Johnstone, Erica, Allen-Brady, Kristina, Welt, Corrine]
通讯作者:
Welt, Corrine
PRL Mutation Causing Alactogenesis: Insights Into Prolactin Structure and Function Relationships.
PRL 突变导致泌乳素生成:深入了解催乳素结构和功能关系。
DOI:
10.1210/clinem/dgab201
发表时间:
2021
期刊:
The Journal of clinical endocrinology and metabolism
影响因子:
--
作者:
[Moriwaki,Mika, Welt,CorrineK]
通讯作者:
Welt,CorrineK
Translational Control in Oogenesis and Embryogenesis
-
批准号:10222743
-
项目类别:
-
资助金额:$32.13万
-
财政年份:2020
-
负责人:CORRINE K WELT
-
依托单位:
Translational Control in Oogenesis and Embryogenesis
-
批准号:10461037
-
项目类别:
-
资助金额:$32.13万
-
财政年份:2020
-
负责人:CORRINE K WELT
-
依托单位:
Primary Ovarian Insufficiency: Etiology and Comorbid Disease
-
批准号:10165773
-
项目类别:
-
资助金额:$31.76万
-
财政年份:2019
-
负责人:CORRINE K WELT
-
依托单位:
Primary Ovarian Insufficiency: Etiology and Comorbid Disease
-
批准号:10626075
-
项目类别:
-
资助金额:$31.76万
-
财政年份:2019
-
负责人:CORRINE K WELT
-
依托单位:
Primary Ovarian Insufficiency: Etiology and Comorbid Disease
-
批准号:10011842
-
项目类别:
-
资助金额:$32.41万
-
财政年份:2019
-
负责人:CORRINE K WELT
-
依托单位:
Primary Ovarian Insufficiency: Etiology and Comorbid Disease
-
批准号:10407050
-
项目类别:
-
资助金额:$31.76万
-
财政年份:2019
-
负责人:CORRINE K WELT
-
依托单位:
The Genetics of Polycystic Ovary Syndrom
-
批准号:8680042
-
项目类别:
-
资助金额:$33.79万
-
财政年份:2010
-
负责人:CORRINE K WELT
-
依托单位:
The Genetics of Polycystic Ovary Syndrom
-
批准号:7993189
-
项目类别:
-
资助金额:$36.22万
-
财政年份:2010
-
负责人:CORRINE K WELT
-
依托单位:
The Genetics of Polycystic Ovary Syndrom
-
批准号:8469069
-
项目类别:
-
资助金额:$32.99万
-
财政年份:2010
-
负责人:CORRINE K WELT
-
依托单位:
The Genetics of Polycystic Ovary Syndrom
-
批准号:8144346
-
项目类别:
-
资助金额:$34.77万
-
财政年份:2010
-
负责人:CORRINE K WELT
-
依托单位:
The Genetics of Polycystic Ovary Syndrom
-
批准号:8291166
-
项目类别:
-
资助金额:$34.77万
-
财政年份:2010
-
负责人:CORRINE K WELT
-
依托单位:
THE EFFECT OF PROLACTIN ON LACTATION
-
批准号:7719327
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2008
-
负责人:CORRINE K WELT
-
依托单位:
RECOMBINANT HUMAN PROLACTIN FOR LACTATION INDUCTION/ PROLACTIN DEFICIENT MOTHERS
-
批准号:7731257
-
项目类别:
-
资助金额:$0.57万
-
财政年份:2008
-
负责人:CORRINE K WELT
-
依托单位:
CLINICAL TRIAL: THE EFFECT OF PROLACTIN ON LACTATION
-
批准号:7731253
-
项目类别:
-
资助金额:$0.18万
-
财政年份:2008
-
负责人:CORRINE K WELT
-
依托单位:
THE EFFECT OF PROLACTIN ON LACTATION
-
批准号:7607386
-
项目类别:
-
资助金额:$0.64万
-
财政年份:2007
-
负责人:CORRINE K WELT
-
依托单位:
THE EFFECT OF PROLACTIN ON LACTATION
-
批准号:7607058
-
项目类别:
-
资助金额:$0.45万
-
财政年份:2006
-
负责人:CORRINE K WELT
-
依托单位:
THE EFFECT OF PROLACTIN ON LACTATION
-
批准号:7379263
-
项目类别:
-
资助金额:$0.4万
-
财政年份:2006
-
负责人:CORRINE K WELT
-
依托单位:
Phase 2 Trial of Recombinant Human Prolactin for Lactation Insufficiency
-
批准号:7373642
-
项目类别:
-
资助金额:$21.94万
-
财政年份:2005
-
负责人:CORRINE K WELT
-
依托单位:
Phase 2 Trial of Recombinant Human Prolactin for Lactation Insufficiency
-
批准号:6958363
-
项目类别:
-
资助金额:$21.94万
-
财政年份:2005
-
负责人:CORRINE K WELT
-
依托单位:
THE EFFECT OF PROLACTIN ON LACTATION
-
批准号:7204545
-
项目类别:
-
资助金额:$0.24万
-
财政年份:2005
-
负责人:CORRINE K WELT
-
依托单位:
海外基金